Radiation-induced lung injury after concurrent neoadjuvant chemoradiotherapy for locally advanced breast cancer

References

• Shenkier T, Weir L, Levine M, Olivotto I, Whelan T, Reyno L. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. Can Med Assoc J 2004;170:983–94.
   PubMed Web of Science ®Google Scholar
• Therasse P, Mauriac L, Welnicka-Jaskiewicz M, Bruning P, Cufer T, Bonnefoi H, et al. Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: An EORTC-NCIC-SAKK multicenter study. J Clin Oncol 2003;21:843–50.
   PubMed Web of Science ®Google Scholar
• Kong X, Moran MS, Zhang N, Haffty B, Yang Q. Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients. Eur J Cancer 2011;47:2084–90.
   PubMed Web of Science ®Google Scholar
• Adams S, Chakravarthy AB, Donach M, Spicer D, Lymberis S, Singh B, et al. Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: Pathologic response correlates with five-year overall survival. Breast Cancer Res Treat 2010;124:723–32.
   PubMed Web of Science ®Google Scholar
• Matuschek C, Bolke E, Roth SL, Orth K, Lang I, Bojar H, et al. Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: Results of a multivariate analysis. Strahlenther Onkol 2012; 188:777–81.
   PubMed Web of Science ®Google Scholar
• Formenti SC, Volm M, Skinner KA, Spicer D, Cohen D, Perez E, et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial. J Clin Oncol 2003;21:864–70.
   PubMed Web of Science ®Google Scholar
• Phernambucq EC, Palma DA, Vincent A, Smit EF, Senan S. Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer. Lung Cancer 2011;74:451–6.
   PubMed Web of Science ®Google Scholar
• Palma DA, van Sornsen de Koste JR, Verbakel WF, Senan S. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol 2011;50:509–17.
   PubMed Web of Science ®Google Scholar
• Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, et al. Technical factors associated with radiation pneumonitis after local +/2 regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 2002;52:137–43.
   PubMed Web of Science ®Google Scholar
• Whelan TJ, Olivotto I, Ackerman I, Chapman JW, Chua B, Nabid A, et al. NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol29:2011(Suppl; abstr LBA1003).
   Google Scholar
• Ghobadi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S, et al. Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 2010;76:548–56.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang J, Zhou S, Hubbs JL, Foltz RJ, Hollis DR, et al. Regional lung density changes after radiation therapy for tumors in and around thorax. Int J Radiat Oncol Biol Phys 2010;76:116–22.
   PubMed Web of Science ®Google Scholar
• Bernchou U, Schytte T, Bertelsen A, Bentzen SM, Hansen O, Brink C. Time evolution of regional CT density changes in normal lung after IMRT for NSCLC. Radiother Oncol 2013;109:89–94.
   PubMed Web of Science ®Google Scholar
• Ding X, Ji W, Li J, Zhang X, Wang L. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer. Radiat Oncol 2011;6:24.
   PubMed Web of Science ®Google Scholar
• Varga Z, Cserháti A, Kelemen G, Boda K, Thurzó L, Kahán Z. Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2011;80:1109–16.
   PubMed Web of Science ®Google Scholar
• Parashar B, Edwards A, Mehta R, Pasmantier M, Wernicke AG, Sabbas A, et al. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol 2011;34:160–4.
   PubMed Web of Science ®Google Scholar
• Onishi H, Kuriyama K, Yamaguchi M, Komiyama T, Tanaka S, Araki T, et al. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: A good local response but no good survival due to radiation pneumonitis. Lung Cancer 2003;40:79–84.
   PubMed Web of Science ®Google Scholar
• Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 2013;85:444–50.
   PubMed Web of Science ®Google Scholar
• Bellon JR, Lindsley KL, Ellis GK, Gralow JR, Livingston RB, Austin Seymour MM. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys 2000;48:393–7.
   PubMed Web of Science ®Google Scholar
• Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012;51:975–83.
   PubMed Web of Science ®Google Scholar
• Rodrigues G, Lock M, D’Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer – a systematic review. Radiother Oncol 2004;71:127–38.
   PubMed Web of Science ®Google Scholar